| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Zhibao Technology Inc. (NASDAQ:ZBAO) ("Zhibao," "we," or the "Company"), a leading and high growth InsurTech company primarily engaging in providing digital insurance brokerage services through its operating entities in China, today announced its wholly owned subsidiary Zhibao Health, has officially launched the "Ren Ren Kang Yue" product in collaboration with the People's Insurance Company of China ("PICC") on August 26, 2025.
This new product is a middle-market medical insurance product designed to cover the needs of urban residents, between the ages of 20-50 years old, within China. With a slogan of "mid-end prices, high-end quality," this product includes convenient services including direct billing, access to the VIP or International wards of public hospitals in China, and access to selected private providers, while remaining affordable to meet the needs of young professionals and families. Within the Chinese medical system, VIP and International wards provide access to premium medical services within the setting of the wider hospital, allowing patients access to high-end services while still retaining access to the doctors and resources of leading public hospitals.
Posted In: ZBAO
